Testing effectiveness (Phase 2)Ended earlyNCT02718391
What this trial is testing
Complementary Vaccination With Dendritic Cells Pulsed With Autologous Tumor Lysate in Resected Stage III and IV Melanoma Patients.
Who this might be right for
Malignant MelanomaAdjuvant Drug TherapyVaccin Therapy
Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS 12